Randomized controlled trial of adjuvant uracil–tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer
British journal of surgery2007Vol. 94(12), pp. 1468–1476
Citations Over TimeTop 10% of 2007 papers
Toshifusa Nakajima, Taira Kinoshitá, Atsushi Nashimoto, Motonori Sairenji, Toshiharu Yamaguchi, Junichi Sakamoto, Tsuneaki Fujiya, Tsukasa Inada, Mitsuru Sasako, Yasuo Ohashi
Abstract
NCT00152243 (http://www.clinicaltrials.gov).
Related Papers
- → Development of a Pharmacokinetic Model to Optimize the Dosage Regimen of TS-1, a Combination Preparation of Tegafur, Gimeracil and Oteracil Potassium(2007)11 cited
- → Safety of alternate-day treatment with TS-1<sup>TM</sup> (tegafur/gimeracil/oteracil) in tumor-bearing dogs: a pilot study(2021)1 cited
- [Level of inhibition of thymidylate synthase activity and 5-fluorouracil in tumor tissues after administration of UFT or tegafur].(1989)
- [Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)].(1985)
- [Sequential changes in blood concentrations of tegafur and 5-FU during oral administration of fine granules of tegafur in patients with primary liver cancer].(1982)